Crown Laboratories Acquires Revance Therapeutics, Expanding Aesthetic Portfolio
The deal expands Crown’s presence in the aesthetics market, bringing Daxxify and the RHA Collection into its portfolio.
The deal expands Crown’s presence in the aesthetics market, bringing Daxxify and the RHA Collection into its portfolio.
Engineered for implants up to 1500cc, the next-generation delivery system supports a “no-touch” technique to improve control, reduce friction, and minimize risks such as infection and capsular contracture.